Rodenticides Market Projected to Reach $8.83 Billion by 2031
The global rodenticides market is expected to grow from an estimated $6.61 billion in 2026 to $8.83 billion by 2031, at a CAGR of 6.0%. Growth is driven by urbanization and increased pest infestations.
The global rodenticides market is projected to expand from an estimated USD 6.61 billion in 2026 to USD 8.83 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.0% during the forecast period. This growth is primarily attributed to increasing urbanization, expanding agricultural and commercial activities, and a rise in rodent infestations across various sectors.
North America held the largest revenue share in 2025. Looking at product types, the software & services segment is anticipated to show the highest CAGR of 6.6% from 2026 to 2031. Pellets are expected to be the fastest-growing application mode, while mice are projected to be the leading target rodent type with a CAGR of 6.2%. Urban centers are estimated to dominate the market in terms of end use.
Chemical rodenticides are expected to maintain a significant market share due to their proven efficacy and widespread availability. Both anticoagulant and non-anticoagulant formulations are commonly employed. The market is also seeing a rise in safer alternatives, known as bio-rodenticides. Key manufacturers in this sector include Bell Laboratories, Neogen Corporation, and Liphatech.
Europe is anticipated to capture a substantial market share, influenced by increasing rodent issues and stringent food safety and public health regulations. Well-established pest control services and the acceptance of diverse application methods, including pellets, further support market growth in the region. The demand for eco-friendly and low-toxicity formulations is also on the rise.